[Insight on how to assess and improve the response to the COVID-19 pandemic].

Reflexiones sobre cómo evaluar y mejorar la respuesta a la pandemia de COVID-19.
COVID-19 Determinantes sociales de salud Evaluación Evaluation Health services research Investigación sobre servicios de salud Pandemia Pandemic Policy responses Prevención y control Prevention and control Respuestas políticas Social determinants of health

Journal

Gaceta sanitaria
ISSN: 1578-1283
Titre abrégé: Gac Sanit
Pays: Spain
ID NLM: 8901623

Informations de publication

Date de publication:
Historique:
received: 26 11 2020
accepted: 27 11 2020
pubmed: 2 2 2021
medline: 21 1 2022
entrez: 1 2 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has hit Spain particularly hard, despite being a country with a developed economy and being praised for the robustness of its national health system. In order to understand what happened and to identify how to improve the response, we believe that an independent multi-disciplinary evaluation of the health, political and socio-economic spheres is essential. In this piece we propose objectives, principles, methodology and dimensions to be evaluated, as well as outlining the type of results and conclusions expected. Inspired by the requirements formulated by the WHO Independent Panel for Pandemic Preparedness and Response and by experiences in other countries, we detail the multidimensional aspects to be evaluated. The goal is to understand key aspects in the studied areas and their scope for improvement in terms of preparedness, governance, regulatory framework, national health system structures (primary care, hospital, and public health), education sector, social protection schemes, minimization of economic impact, and labour framework and reforms for a more resilient society. We seek to ensure that this exercise serves not only at present, but also that in the future we are better prepared and more agile in terms of our ability to recover from any pandemic threats that may arise.

Identifiants

pubmed: 33518411
pii: S0213-9111(20)30254-5
doi: 10.1016/j.gaceta.2020.11.008
pmc: PMC7834448
pii:
doi:

Types de publication

Journal Article

Langues

spa

Sous-ensembles de citation

IM

Pagination

32-36

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.

Références

Am J Public Health. 2020 Nov;110(11):1605-1610
pubmed: 32816552
BMJ. 2013 Jun 13;346:f2363
pubmed: 23766463
Clin Infect Dis. 2021 Feb 16;72(4):697-702
pubmed: 32544242
Annu Rev Public Health. 2007;28:33-54
pubmed: 17222081
BMJ. 2009 Mar 30;338:b1170
pubmed: 19332452
N Engl J Med. 2020 Oct 8;383(15):1483-1488
pubmed: 32706956
Lancet. 2018 Jun 2;391(10136):2236-2271
pubmed: 29893224
Lancet Public Health. 2020 Nov;5(11):e575
pubmed: 32971009
Lancet. 2020 Sep 26;396(10255):874
pubmed: 32979964
Lancet. 2020 Aug 22;396(10250):529-530
pubmed: 32771082
Nat Med. 2020 Jul;26(7):1005-1008
pubmed: 32528155
BMJ. 2020 May 22;369:m2052
pubmed: 32444349

Auteurs

José M Martín-Moreno (JM)

Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina e INCLIVA, Universitat de València, Valencia, España. Electronic address: jose.martin-moreno@uv.es.

Alex Arenas (A)

Departament d'Enginyeria Informàtica i Matemàtiques, Universitat Rovira i Virgili, Tarragona, España.

Rafael Bengoa (R)

Instituto de Salud y Estrategia, Bilbao, España.

Carme Borrell (C)

Agència de Salut Pública de Barcelona, Barcelona, España; CIBER de Epidemiología y Salud Pública (CIBERESP), España.

Manuel Franco (M)

Grupo de Investigación en Epidemiología y Salud Pública, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Alcalá de Henares, Madrid, España; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Alberto L García-Basteiro (AL)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, España; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

Juan Gestal (J)

Universidad de Santiago de Compostela, España.

Beatriz González López-Valcárcel (B)

Universidad de Las Palmas de Gran Canaria, España.

Ildefonso Hernández Aguado (I)

CIBER de Epidemiología y Salud Pública (CIBERESP), España; Universidad Miguel Hernández, Elche, España.

Helena Legido-Quigley (H)

London School of Hygiene and Tropical Medicine and Saw Swee Hock School of Public Health, University of Singapore.

Joan Carles March (JC)

Escuela Andaluza de Salud Pública, Granada, España.

Sergio Minué (S)

Escuela Andaluza de Salud Pública, Granada, España.

Carles Muntaner (C)

University of Toronto y Center for Urban Health Solucions, Li Ka Shing Knowledge Institute, Canadá.

Carmen Vives-Cases (C)

CIBER de Epidemiología y Salud Pública (CIBERESP), España; Universidad de Alicante, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH